Investigative journalist Katherine Eban set out to report on a seemingly straightforward question: Are generic drugs really identical to their brand-name counterparts? The answer sparked a decade of interviews, meetings with whistleblowers, on-the-ground reporting across four continents and digging into confidential FDA documents. In this alarming talk, she takes us inside overseas manufacturing plants and exposes the fraud behind many low-cost generic medicines.
调查记者凯瑟琳·艾班(Katherine Eban)开始着手报道一个看似直接的问题:仿制药是否真正等效于它们的同名品牌药?寻找这个问题的答案激发了长达十年的采访、与知情者的会面、跨越四大洲的实地探访,以及对美国食物及药品管理局(FDA)机密文件的深入调查。在这次令人警醒的演讲中,她带我们进入海外的制药厂,并揭露了许多廉价仿制药背后的欺诈。